Hims & Hers Health, Inc. (NYSE:HIMS – Get Rating) insider Irene Becklund sold 10,668 shares of the stock in a transaction on Tuesday, September 20th. The shares were sold at an average price of $5.68, for a total value of $60,594.24. Following the completion of the transaction, the insider now directly owns 6,978 shares in the company, valued at approximately $39,635.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Irene Becklund also recently made the following trade(s):

• On Friday, September 9th, Irene Becklund sold 11,002 shares of Hims & Hers Health stock. The shares were sold at an average price of $6.64, for a total value of $73,053.28.
• On Tuesday, July 5th, Irene Becklund sold 19,331 shares of Hims & Hers Health stock. The shares were sold at an average price of $5.00, for a total value of $96,655.00.

Hims & Hers Health Trading Down 3.7 %

Shares of HIMS opened at $5.47 on Friday. Hims & Hers Health, Inc. has a fifty-two week low of $2.72 and a fifty-two week high of $9.19. The firm has a 50-day simple moving average of $6.22 and a 200-day simple moving average of $5.10.

Wall Street Analyst Weigh In

HIMS has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft increased their target price on Hims & Hers Health from $7.00 to $8.00 in a report on Wednesday, August 10th. Guggenheim raised their price objective on Hims & Hers Health to $12.00 in a report on Monday, August 15th. Credit Suisse Group raised their price objective on Hims & Hers Health from $7.00 to $8.00 and gave the stock an "outperform" rating in a report on Wednesday, August 10th. Piper Sandler dropped their price objective on Hims & Hers Health from $8.00 to $6.00 and set an "overweight" rating on the stock in a report on Thursday, May 26th. Finally, SVB Leerink raised their price objective on Hims & Hers Health from $4.00 to $5.00 and gave the stock an "underperform" rating in a report on Tuesday, August 9th. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, Hims & Hers Health has a consensus rating of "Hold" and an average price target of $7.38.

Institutional Investors Weigh In On Hims & Hers Health

Several hedge funds have recently made changes to their positions in HIMS. Raymond James & Associates acquired a new stake in Hims & Hers Health in the fourth quarter valued at about $205,000. HighTower Advisors LLC lifted its position in Hims & Hers Health by 14.4% in the fourth quarter. HighTower Advisors LLC now owns 31,761 shares of the company's stock valued at $209,000 after purchasing an additional 3,998 shares during the period. Teacher Retirement System of Texas lifted its position in Hims & Hers Health by 25.6% in the fourth quarter. Teacher Retirement System of Texas now owns 14,808 shares of the company's stock valued at $97,000 after purchasing an additional 3,022 shares during the period. Qube Research & Technologies Ltd acquired a new stake in Hims & Hers Health in the fourth quarter valued at about $237,000. Finally, PEAK6 Investments LLC lifted its position in Hims & Hers Health by 18.3% in the fourth quarter. PEAK6 Investments LLC now owns 138,866 shares of the company's stock valued at $910,000 after purchasing an additional 21,526 shares during the period. Institutional investors and hedge funds own 43.41% of the company's stock.

Hims & Hers Health Company Profile

(Get Rating)

Hims & Hers Health, Inc operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care.

Featured Stories

• Get a free copy of the StockNews.com research report on Hims & Hers Health (HIMS)
• The Institutions Hold On To Darden Restaurants International
• What Steelcase's Earnings Say About the Return to the Office?
• These 3 Big Dividend Payers Also Boast Strong Price Growth
• Is The Golden Age Of Homebuilding Already Over?
• Natural Gas Prices Continue To Rally, These Stocks Should Benefit

Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.